Investor Database — 54,000+ VC, PE & angel contacts, the full list for $19.Get the list

Unifortune

Private Investment Firm Guangdong Sheng, China

Overview

Unifortune is a Chinese private investment firm specializing in technology sectors. The firm has been involved in several funding rounds for companies in biotechnology, energy, artificial intelligence, healthcare, and clinical trials. Their investment activities span various stages, including seed, early stage, Series A, Series B, growth, late stage, and pre-IPO. Unifortune's geographical focus is primarily on China, reflecting its commitment to supporting domestic technological advancements. The firm's portfolio includes companies such as Atom Bioscience & Pharmaceutical, Immvira, Guorun Energy Storage, CiDi, and LenoMed Medical. Unifortune's strategic approach emphasizes active involvement in the growth and development of its portfolio companies, aiming to drive innovation and industry leadership within the Chinese market. Their investments are characterized by a focus on sectors with high growth potential and a commitment to fostering technological innovation. This approach underscores Unifortune's role as a significant player in China's private investment landscape, dedicated to supporting the evolution of key industries through strategic investments and partnerships.

Reach Unifortune directly

Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.

Unlock full contacts →

Frequently asked questions about Unifortune

What sectors does Unifortune invest in?

Unifortune invests in Healthcare, Energy, Artificial Intelligence, Biotechnology and Clinical Trials, and is based in Guangdong Sheng, China. Unifortune is listed as a private investment firm in the ConnectSafely investor database.